Close Menu

NEW YORK ─ A group of global health partners on Monday announced a collaboration to develop a rapid diagnostic test for the testing of schistosomiasis, a neglected tropical disease caused by infection with parasitic worms.

The partners are Foundation for Innovative New Diagnostics, Global Health Innovative Technology Fund, Nagasaki University Institute of Tropical Medicine, Leiden University Medical Center, Merck KGaA, and Mologic.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

Amid the COVID-19 pandemic, hospitals and intensive care units around the world have been overwhelmed by unprecedented levels of demand. 

Sponsored by
LGC SeraCare Life Sciences

As we pass the one-year anniversary of both the COVID-19 pandemic and the first Emergency Use Authorized SARS-CoV-2 PCR detection assays, there remains significant opportunity for clinical laboratories to advance testing and support improved patient management.

Sponsored by

This webinar will present the details of a COVID-19 saliva screening program that has been implemented at more than 90 different colleges, universities, private schools, and nursing homes across New York state.